Home/Filings/4/0001493152-24-008930
4//SEC Filing

SAHAREK JOHN P. 4

Accession 0001493152-24-008930

CIK 0001360214other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 6:06 AM ET

Size

7.5 KB

Accession

0001493152-24-008930

Insider Transaction Report

Form 4
Period: 2024-03-01
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
  • Exercise/Conversion

    Common stock

    2024-03-01$8.75/sh+5,000$43,750254,803 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-015,0000 total
    Exercise: $8.75Exp: 2024-03-03Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.

Documents

1 file

Issuer

HARROW, INC.

CIK 0001360214

Entity typeother

Related Parties

1
  • filerCIK 0001632091

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:06 AM ET
Size
7.5 KB